Results 141 to 150 of about 178,855,135 (215)

Outcomes of Bisphosphonate-Related Osteonecrosis Following Head and Neck Free-Flap Reconstruction. [PDF]

OTO Open
Freeman TE, Erickson EL, Seim NB, Old MO, Miller LE.   +4 more
europepmc   +1 more source

Evaluation of Local and Systemic Melatonin Administration on Bone Healing After Tooth Extraction in Bisphosphonate-Treated Rats. [PDF]

BMC Oral Health
Kulfel CG, Alan HT, Yildiz A, Ozhan O.
europepmc   +1 more source

Association between periodontal disease severity and the risk of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis by the Korean Academy of Periodontology. [PDF]

J Periodontal Implant Sci
Lee JH, Kim YJ, Song YW, Kim S, Chung JH, Seol YJ, Lee HJ.   +6 more
europepmc   +1 more source

Clinical and Radiological Outcomes of Oral Bisphosphonate Therapy Combined with Conservative Treatment in Subchondral Bone Marrow Edema of the Knee: A Retrospective Cohort Study. [PDF]

J Clin Med
Yurdakul G, Korkmaz M, Karadak I, Iyigun A, Kazez M, Yayli N, Erkoc MF, Golgelioglu F.   +7 more
europepmc   +1 more source

Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. [PDF]

J Transl Med, 2015
Kalyan S, Wang J, Quabius ES, Huck J, Wiltfang J, Baines JF, Kabelitz D.   +6 more
europepmc   +1 more source

Serum vitamin D Levels in patients with medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. [PDF]

BMC Oral Health
Daneshvar A, Daneshvar K, Musaie F, Dashti S, Yazdi NT, Tabrizi R.   +5 more
europepmc   +1 more source

Osteoclast-derived exosomes promote medication-related osteonecrosis of the jaw by delivering glycoRNA to disrupt the blood-lymphatic vascular network. [PDF]

J Dent Sci
Zhang J, Tao J, Zhao C, Pan J.
europepmc   +1 more source

Quantitative Bone Assessment in Medication-Related Osteonecrosis of the Jaw Using Fractal Analysis: A Systematic Review of the Literature and Clinical Perspectives. [PDF]

Dent J (Basel)
Misiejuk A, Adamska P, Żółtowska A, Zedler A.   +3 more
europepmc   +1 more source

Clinical Characteristics and Serum Vitamin D Levels in Patients with MRONJ Associated with Antiresorptive Therapy: A Retrospective Study. [PDF]

Medicina (Kaunas)
Hum IM, Atyim L, Maracineanu R, Folescu R, Stana LG, Folescu R.   +5 more
europepmc   +1 more source

MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors. [PDF]

Bone Rep
Mammone G, Coropciuc R, Van den Wyngaert T, Jacobs R, Bossier P, Kerkhofs C, Wijnen L, Meerschaert S, Vissenaekens E, Clement PM, Bechter O, Debruyne PR, Laenen A, Beuselinck B.   +13 more
europepmc   +1 more source